Your browser doesn't support javascript.
loading
Stimuli-Sensitive Linear-Dendritic Block Copolymer-Drug Prodrug as a Nanoplatform for Tumor Combination Therapy.
Cai, Hao; Tan, Ping; Chen, Xiaoting; Kopytynski, Michal; Pan, Dayi; Zheng, Xiuli; Gu, Lei; Gong, Qiyong; Tian, Xiaohe; Gu, Zhongwei; Zhang, Hu; Chen, Rongjun; Luo, Kui.
Afiliação
  • Cai H; Huaxi MR Research Center (HMRRC), Department of Radiology, National Clinical Research Center for Geriatrics, Frontiers Science Center for Disease-Related Molecular Network, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, 610041, China.
  • Tan P; Huaxi MR Research Center (HMRRC), Department of Radiology, National Clinical Research Center for Geriatrics, Frontiers Science Center for Disease-Related Molecular Network, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, 610041, China.
  • Chen X; Animal Experimental Center of West China Hospital, Sichuan University, Chengdu, 610041, China.
  • Kopytynski M; Department of Chemical Engineering, Imperial College London, South Kensington Campus, London, SW7 2AZ, UK.
  • Pan D; Huaxi MR Research Center (HMRRC), Department of Radiology, National Clinical Research Center for Geriatrics, Frontiers Science Center for Disease-Related Molecular Network, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, 610041, China.
  • Zheng X; Huaxi MR Research Center (HMRRC), Department of Radiology, National Clinical Research Center for Geriatrics, Frontiers Science Center for Disease-Related Molecular Network, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, 610041, China.
  • Gu L; Huaxi MR Research Center (HMRRC), Department of Radiology, National Clinical Research Center for Geriatrics, Frontiers Science Center for Disease-Related Molecular Network, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, 610041, China.
  • Gong Q; Huaxi MR Research Center (HMRRC), Department of Radiology, National Clinical Research Center for Geriatrics, Frontiers Science Center for Disease-Related Molecular Network, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, 610041, China.
  • Tian X; Functional and Molecular Imaging Key Laboratory of Sichuan Province, and Research Unit of Psychoradiology, Chinese Academy of Medical Sciences, Chengdu, 610041, China.
  • Gu Z; Huaxi MR Research Center (HMRRC), Department of Radiology, National Clinical Research Center for Geriatrics, Frontiers Science Center for Disease-Related Molecular Network, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, 610041, China.
  • Zhang H; Huaxi MR Research Center (HMRRC), Department of Radiology, National Clinical Research Center for Geriatrics, Frontiers Science Center for Disease-Related Molecular Network, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, 610041, China.
  • Chen R; Amgen Bioprocessing Centre, Keck Graduate Institute, Claremont, CA, 91711, USA.
  • Luo K; Department of Chemical Engineering, Imperial College London, South Kensington Campus, London, SW7 2AZ, UK.
Adv Mater ; 34(8): e2108049, 2022 Feb.
Article em En | MEDLINE | ID: mdl-34875724
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 15_ODS3_global_health_risks Base de dados: MEDLINE Assunto principal: Fotoquimioterapia / Porfirinas / Pró-Fármacos / Nanopartículas Tipo de estudo: Diagnostic_studies Idioma: En Revista: Adv Mater Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 15_ODS3_global_health_risks Base de dados: MEDLINE Assunto principal: Fotoquimioterapia / Porfirinas / Pró-Fármacos / Nanopartículas Tipo de estudo: Diagnostic_studies Idioma: En Revista: Adv Mater Ano de publicação: 2022 Tipo de documento: Article